3-(.ALPHA.-ACETONYL-P-NITROBENZYL)-4-HYDROXYCOUMARIN
Vascular Complications
St. Antonius HospitalSmall moleculePhase 4 / ApprovedDormant
BB
69/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 54/ 100
- Competitive Position
- 95/ 100
Competitive context
0 Active assets in the Vascular Complications cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Dabigatran St. Antonius Hospital | Phase 4 | BB |
PHENPROCOUMON St. Antonius Hospital | Phase 4 | BB |
Same molecule, other indications
3-(.ALPHA.-ACETONYL-P-NITROBENZYL)-4-HYDROXYCOUMARIN is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →